Eiman Alzaabi: Sharing Rare Observations and Challenging Assumptions in Transfusion Medicine
Eiman Alzaabi, President of the Transfusion Working Group under the Emirates Medical Association and Medical Director of the SEHA Blood Bank, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
”Scientific progress depends on those who choose to share rare observations and challenge assumptions.
Proud to contribute to the transfusion medicine community with this work—and deeply grateful to an outstanding team whose expertise, persistence, and collaboration made it possible. This is what collective science looks like.”
Title: Anti-Ku alloimmunization due to a KEL*02N.19 allele causing Kell-null phenotype despite KEL*02 genotype prediction
Authors: Ravi C. Dara, Rania Madkour, Kathleen Bensing, Eiman Alzaabi, Ihsanullah Sadiq, Nyaradzo Chada, Ghada H. Mawad, Kathleen E. Puca, Manuel Algora
Read the Full Article on Vox Sanguinis.
Stay updated with Hemostasis Today.
-
Apr 13, 2026, 10:57José Antonio García Erce: Situation of Immunoglobulins in Spain
-
Apr 13, 2026, 09:51Caitlin Raymond: Jehovah’s Witnesses Can Now Accept Their Own Blood But It Is Still Not That Simple
-
Apr 13, 2026, 09:12We Are Pleased to Welcome Rajneesh Jain as the New Chief Executive Officer – Hemophilia Federation (India)
-
Apr 13, 2026, 08:52Deborah Holzapfel: The Reality for Women with Hemophilia B
-
Apr 13, 2026, 08:35Sara Altayeb: ESC 2026 Clinical Pearls for Bleeding on Anticoagulation
-
Apr 13, 2026, 07:58The Case for Greater Investment in VTE Research – JTH
-
Apr 13, 2026, 07:44Mattia Galli: A Clinicial Guide to Navigating Bleeding on Anticoagulant Therapy
-
Apr 13, 2026, 07:31Explore the Power of Guidelines in Hemophilia Care – EAHAD
-
Apr 13, 2026, 06:57Heghine Khachatryan: Why PNH Is More Than a Hemolytic Disease